Vorinostat in Treating Patients With Kidney Cancer

Clinical trial NCT00278395 · COMPLETED

Trial details

NCT number: NCT00278395
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer

Start date: 2005-10-01
Primary completion: 2010-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.